Transapical aortic valve prosthetic endocarditis.
An 83-year-old patient underwent a transapical aortic valve implantation at our institution. Four months later, she was readmitted to our institution because of fever and heart failure. A prosthetic aortic valve endocarditis was diagnosed. Because of the high surgical risk, surgery was refused and the patient died shortly after the diagnosis. We briefly discuss the implications of this finding in the prevention of infective endocarditis after transcatheter aortic valve implantation.
Carnero-Alcázar
Manuel
M
Department of Cardiac Surgery, Hospital Clinico San Carlos, Madrid, Spain. manuelcarneroalcazar@hotmail.es
Maroto Castellanos
Luis Carlos
LC
Carnicer
Javier Cobiella
JC
Rodríguez Hernández
José Enrique
JE
D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001024:Aortic Valve Stenosis / Q000628:therapy*; D006328:Cardiac Catheterization / Q000009:adverse effects* / Q000295:instrumentation; D004697:Endocarditis, Bacterial / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000382:microbiology*; D013293:Enterococcus faecalis / Q000302:isolation & purification*; D017809:Fatal Outcome; D005260:Female; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects* / Q000295:instrumentation; D006801:Humans; D016459:Prosthesis-Related Infections / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000382:microbiology*; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014463:Ultrasonography
D000900:Anti-Bacterial Agents